Here we use integrative single-cell immuno-transcriptomics to characterize three distinct liver-self-antigen-specific CD4 T cell reactivities and expanded intrahepatic CD4 T cell clonotypes in the blood of AILD patients. This evidence concerns the gene CD4 and angioimmunoblastic T-cell lymphoma.